RP2 and glioma: Moreover, our TIDE results also displayed that the effect of glioma immunotherapy was awful in the case of high RP2 expression, which just confirmed the above theory, and also suggested us that effective inhibition of RP2 overexpression in glioma is likely to improve the effect of immunotherapy and increase the survival hope of patients.